New Assessment System in Measuring Symptom Distress in Cancer Patients

RecruitingOBSERVATIONAL
Enrollment

6,500

Participants

Timeline

Start Date

April 13, 1999

Primary Completion Date

April 30, 2031

Study Completion Date

April 30, 2031

Conditions
CaregiverHealth Care ProviderMalignant NeoplasmPhysician
Interventions
OTHER

Interview

Complete interview

OTHER

Quality-of-Life Assessment

Complete quality of life assessment

OTHER

Questionnaire Administration

Complete questionnaires

Trial Locations (1)

77030

RECRUITING

M D Anderson Cancer Center, Houston

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

collaborator

Bayer

INDUSTRY

collaborator

Bristol-Myers Squibb

INDUSTRY

collaborator

Eli Lilly and Company

INDUSTRY

collaborator

Genentech, Inc.

INDUSTRY

collaborator

Merck Sharp & Dohme LLC

INDUSTRY

collaborator

National Institutes of Health (NIH)

NIH

lead

M.D. Anderson Cancer Center

OTHER